Focus
Cell Therapy Investors: Angels and VC Firms
The RaiseHunt database lists 146 Cell Therapy investors: 11 angel investors and 135 people at 42 firms. Most list Seed and Series B among their stages; the largest hubs are San Francisco, New York and London.
Strongest in San Francisco, New York and London
- 146
- Cell Therapy investors
- 11
- Angel investors
- 135
- People at VC/PE firms
- 42
- Firms tagged
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
146 Cell Therapy investors
Showing 141-146
| Investor | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
GA Gregory A Bonfiglio Founder at Proteus | Portola Valley, United States | Venture capital | Healthcare | View profile | |
JW Jian Wang Investment Director at Elikon Venture | Shanghai, China | Venture capital | Healthcare | View profile | |
DP David Parry Venture Partner at Samsara BioCapital | Mountain View, United States | Venture capital | Healthcare | View profile | |
PH Philip Habib Managing Director at SR One Capital Management | London, United Kingdom | Venture capital | Healthcare | View profile | |
MD Michael Diem Partner at SR One Capital Management | Conshohocken, United States | Venture capital | Healthcare | View profile | |
QY Qinda Ye Superstring Capital Management LP at Superstring Capital | New York, United States | Private equityVenture capital | Healthcare | View profile |
Data: RaiseHunt investor dataset · Snapshot 27 August 2026 · How this data is built · Report a correction or request removal